Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types

R. Moussa(Robert Bosch (Australia)), Des R. Richardson(Children's Cancer Institute Australia)
Oncotarget
August 22, 2015
Cited by 17


Related Papers